Table 3. Incidence of malignant eyelid tumors reported in different studies from Asia, NA, and Europe.
Region | BCC | SGC | SCC | MM |
Asia | ||||
China & Korea (this study) | 46.7 | 29.3 | 9.3 | 13.3 |
Taiwan[14] | 62.2 | 23.6 | 8.7 | 3.9 |
Japan[15] | 39.5 | 28.9 | 10.5 | 7.9 |
India[35] | 48.2 | 31.2 | 13.7 | 4.7 |
NA | ||||
Minnesota[28] | 90.8 | - | 8.6 | 0.6 |
Alabama[29] | 83.7 | 1.7 | 10.3 | 2.6 |
Europe | ||||
Switzerland[16] | 86 | 3 | 7 | 0.2 |
Romania[2] | 72.5 | 2 | 19.6 | 5.9 |
BCC: Basal cell carcinoma; SGC: Sebaceous gland carcinoma; SCC: Squamous cell carcinoma; MM: Malignant melanoma.
(%)